Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease

Kyoka Hoshi(Fukushima Medical University), Yasuhiro Hashimoto(Fukushima Medical University)

Metabolites

September 10, 2021

10.3390/metabo11090616

Cited by 34

Related Papers

Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus

|PLoS ONE|2017|44

High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease

|Metabolites|2022|5

Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases

|International Journal of Molecular Sciences|2023|1